Tuesday, July 29, 2014 Last update: 5:33 AM
FreshNews.com - All Company Technology News Since 1996

Amneal Pharmaceuticals Implements QUMAS Compliance and Quality Management Solution

Companies mentioned in this article: QUMAS

JERSEY CITY, NJ -- (Marketwired) -- 03/04/14 -- QUMAS, an Accelrys company (NASDAQ: ACCL), today announced that Amneal Pharmaceuticals LLC is now leveraging QUMAS DocCompliance and ProcessCompliance to manage all quality documents and resolve any customer issues across ten facilities located in the U.S. and India. According to IMS Health, Amneal is the 7th largest generic drug manufacturer in the U.S. market based on number of prescriptions dispensed.

These QUMAS software solutions deliver comprehensive capabilities around document management (SOPs, methods, procedures, etc.) and process management (CAPAs, deviations, customer issues, etc.), presenting all activities through MyQUMAS, a web-based user interface, with consolidated reporting and dashboarding, all driving regulatory compliance, quality assurance and ultimately delivering better business performance.

"The initial deployment went smoothly," stated David Miller, Vice President of Quality for Amneal Pharmaceuticals. "Now that we are up and running in the quality departments at all of our sites we are currently making plans to roll out the QUMAS platform to additional departments in the company."

"This engagement with Amneal reinforces our position as the leading provider of regulatory compliance and quality solutions to the life sciences industry," said Kevin O'Leary, CEO for QUMAS. "We have a large generic pharmaceutical manufacturer client base globally, and continue to see this area of the life sciences sector grow in strength."

About QUMAS

QUMAS is the leader in Enterprise Compliance Solutions with more than 270 global customer deployments and two decades of experience helping companies in highly regulated industries. QUMAS is a Gold Microsoft Partner, and provides the QUMAS Compliance Platform on SharePoint 2010, Documentum, Oracle or SQL. For more information, visit www.qumas.com.

About Accelrys

QUMAS is an Accelrys company. Accelrys (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. Accelrys offers capabilities in scientific data management, modeling and simulation, research informatics, laboratory informatics, enterprise quality management, environmental health & safety and operations intelligence for customers in science-driven industries. Using Accelrys technology, scientific organizations can access, organize, analyze and share data in unprecedented ways across the research, laboratory and manufacturing continuum, ultimately enhancing innovation, improving productivity and compliance, reducing costs and accelerating product development from research to manufacturing. For more information about Accelrys, visit www.accelrys.com.

All trade names, trademarks, and service marks are rightful property of their respective owners.


Contact:

MEDIA CONTACT:
Caoimhe Kiely
VP Marketing
QUMAS
+353 21 4915100
Email Contact
www.qumas.com